PET/MRI 및 MR-IGRT를 위한  MRI 기반 합성 CT 생성의 타당성 연구 by 안현준
 
 
저 시-비 리- 경 지 2.0 한민  
는 아래  조건  르는 경 에 한하여 게 
l  저 물  복제, 포, 전송, 전시, 공연  송할 수 습니다.  
다 과 같  조건  라야 합니다: 
l 하는,  저 물  나 포  경 ,  저 물에 적 된 허락조건
 명확하게 나타내어야 합니다.  
l 저 터  허가를 면 러한 조건들  적 되지 않습니다.  
저 에 른  리는  내 에 하여 향  지 않습니다. 




저 시. 하는 원저 를 시하여야 합니다. 
비 리. 하는  저 물  리 목적  할 수 없습니다. 







Feasibility study of MRI-based  
synthetic CT generation  
for PET/MRI and MR-IGRT  
 
 
PET/MRI 및 MR-IGRT를 위한  
















Thesis for the Degree of  
Doctor of Philosophy in Science 
 
 
Feasibility study of MRI-based  
synthetic CT generation  
for PET/MRI and MR-IGRT 
 
 
PET/MRI 및 MR-IGRT를 위한  








Seoul National University Graduate School 




PET/MRI 및 MR-IGRT를 위한  




지도 교수  이 재 성 
 
이 논문을 이학박사 학위논문으로 제출함 




안 현 준 
 
안현준의 이학박사 학위논문을 인준함 
2020 년 8 월 
 
위 원 장                          (인) 
부위원장                          (인) 
위    원                          (인) 
위    원                          (인) 
위    원                          (인)
 
 
Feasibility study of MRI-based  
synthetic CT generation  
for PET/MRI and MR-IGRT  
  
 
Examiner Jae Sung Lee 
 





Seoul National University Graduate School 
Major in Biomedical Sciences 
Hyun Joon An 
 
Confirming the Ph.D. Dissertation written by 
Hyun Joon An  
August 2020 
 
Chair                      (Seal) 
Vice Chair                     (Seal) 
Examiner                     (Seal) 
Examiner                     (Seal) 






Feasibility study of MRI-based  
synthetic CT generation  
for PET/MRI and MR-IGRT 
 
Hyun Joon An 
Major in Biomedical Sciences  
Department of Biomedical Sciences  
Seoul National University Graduate School 
 
Over the past decade, the application of magnetic resonance imaging (MRI) in 
the field of diagnosis and treatment has increased. MRI provides higher soft-tissue 
contrast, especially in the brain, abdominal organ, and bone marrow without the 
expose of ionizing radiation. Hence, simultaneous positron emission 
tomography/MR (PET/MR) system and MR-image guided radiation therapy (MR-
IGRT) system has recently been emerged and currently available for clinical study. 
One major issue in PET/MR system is attenuation correction from MRI scans 
for PET quantification and a similar need for the assignment of electron densities to 
MRI scans for dose calculation can be found in MR-IGRT system. Because the MR 
signals are related to the proton density and relaxation properties of tissue, not to 
electron density. To overcome this problem, the method called synthetic CT (sCT), 
a pseudo CT derived from MR images, has been proposed. In this thesis, studies on 
generating synthetic CT and investigating the feasibility of using a MR-based 
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synthetic CT for diagnostic and radiotherapy application were presented.  
Firstly, MR image-based attenuation correction (MR-AC) method using level-
set segmentation for brain PET/MRI was developed. To resolve conventional 
inaccuracy MR-AC problem, we proposed an improved ultrashort echo time MR-
AC method that was based on a multiphase level-set algorithm with main magnetic 
field inhomogeneity correction. We also assessed the feasibility of level-set based 
MR-AC method, compared with CT-AC and MR-AC provided by the manufacturer 
of the PET/MRI scanner. 
Secondly, we proposed sCT generation from the low field MR images using 2D   
convolution neural network model for MR-IGRT system. This sCT images were 
compared to the deformed CT generated using the deformable registration being 
used in the current system. We assessed the feasibility of using sCT for radiation 
treatment planning from each of the patients with pelvic, thoraic and abdominal 
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Chapter 1. Introduction 
1.1. Background  
1.1.1. The Integration of MRI into Other Medical Devices 
Magnetic resonance imaging (MRI) is one of the most prominently used 
medical imaging equipment for diagnostic purpose. MRI system use strong magnetic 
fields and radiofrequency pulse to make an image of the internal structures of the 
body. The signal comes primarily from the protons in fat and water molecules in the 
body. 
The advantages of MRI over other imaging modalities include superior soft 
tissue contrast especially in the brain, abdominal organ, and bone marrow without 
the expose of ionizing radiation. MRI can also provide functional and molecular 
information, such as diffusion imaging, perfusion imaging, and functional MRI (1). 
To take advantage of these MRI characteristics, the application of MRI into 
other medical equipment in the diagnostic and therapeutic field has increased rapidly 
in the past decade. As a result, positron emission tomography/MRI (PET/MRI) 
system and MR-image guided radiation therapy (MR-IGRT) system has recently 
been emerged and currently available for clinical study.  
 
1.1.1.1 PET/MRI 
For diagnostic purpose, PET is a molecular imaging modality that provides 
quantitative physiological information. Although PET is the most sensitive medical 
imaging device providing functional and biochemical information, it has limited 
spatial resolution, signal to noise ratio, and anatomical information. On the other 
hand, MRI offers detail anatomical information with excellent soft tissue contrast, 
 
 ２
such as brain, head and neck, liver and pelvis. Accordingly, the combination of PET 
and MRI shows various possibilities as new methodology.  
In addition, fully integrated PET/MRI scanners based on semi-conductor 
photosensors, such as avalanche photodiode and silicon photomultiplier allows the 
simultaneous acquisition of both image data sets, which possess several distinct 
advantages over the sequential scan in conventional PET/CT examination (1-5). 
Simultaneous PET and MRI data acquisition has several advantages including 
temporal and spatial correlation of PET and MRI data. Motion correction and partial 
volume effect correction of the PET data can be implemented using the MRI 
information. Additionally, more accurate arterial input function for dynamic PET can 
be obtained using image-based approaches (6).  
 
1.1.1.2 MR-IGRT 
The goal of radiation therapy is to deliver radiation to the planned target 
volumes as precisely and accurately as possible while minimizing dose to critical 
normal tissues. IGRT is a method of radiation therapy that incorporates imaging 
techniques to ensure a precise dose delivery (7, 8).   
IGRT is particularly applicable to highly conformal radiotherapy such as 3D 
conformal radiation therapy (3D-CRT) and intensity-modulated radiation therapy 
(IMRT) (9). In the treatment of high-dose, low-fractionaion therapy such as 
stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy 
(SABR) , IGRT is considered an essential component of the of the entire procedure 
(10). 
Currently, imaging techniques such as mega-voltage planar imaging, kilo-
voltage planar imaging, and cone-beam CT are commonly used to optimize 
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treatment positioning. However, all of these still have the problem of poor soft tissue 
contrast, and as a result, it still remains challenging to distinguish tumor from normal 
tissues (11, 12). 
To solve this problem, MR-IGRT system has been developed and currently 
available (13-15). The integration of MRI into radiation treatment system provides 
a high tumor visibility and surrounding tissue anatomy. It also provides real-time 
imaging to characterize and track anatomical movements using fast sequence 
imaging. Respiratory gating by MRI is particularly advantageous in several aspects 
for high dose SBRT (16, 17). It enables motion mitigation and a reduction of 
planning target volume (PTV) margins and allows for an accurate dose delivery to 






Figure 1-1.  MR-integrated medical system. (A) PET/MRI : Siemens Biograph mMR 




1.1.2. Chanllenges in the MRI Integrated System 
1.1.2.1 Attenuation Correction for PET/MRI 
Despite the advantage of simultaneous PET/MR imaging, one of the most 
challenging issues in PET/MR system is attenuation correction (AC) which is an 
essential procedure for quantitative PET imaging. In PET/CT, the attenuation map 
(μ-map) can be derived from CT transmission data and converting the Hounsfield 
units to μ values for 511 keV using bilinear transform (18, 19). In PET/MR, there is 
no mechanism to directly measure the attenuation coefficient of the tissue due to 
space constraint and magnetic induced artifact. The MR signals are related to the 
proton density and relaxation properties of tissue, not to electron density. It is 
therefore necessary to derive μ-map from the PET or MRI data. 
 
1.1.2.2 Electron Density for Dose Calculation of MR-IGRT 
The electron density is an essential factor for accurate dose calculation. During 
treatment planning, the treatment planning systems (TPS) use a conversion of the 
Hounsfield numbers to relative electron density to calculate dose (20, 21). This can 
be done through use of generic formulas or tissue look up table. A look up table can 
help account for the effects of variations in atomic number Z between different 
tissues. 
However, in MR-IGRT system, the MRI lack any intrinsic relationship to the 
electron density. As a result, additional CT simulation (CT-SIM) imaging is required 
to know the radiation dose distribution. In the standard MR-IGRT workflow, the CT 
simulation is used for dose calculation and treatment planning with daily MR images 
co-registered to the CT-SIM images by applying rigid or deformable registration and 
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assigning an electron density map obtained from the registered CT. 
 
1.1.3. Synthetic CT Generation  
In recent years, interests in deriving CT data from MRI data have grown rapidly. 
Several methods have been proposed for using MR images to generate a synthetic 
CT (sCT) image. These methods can broadly be classified into 3 groups : template(or 
atlas)-based, segmentation-based, and learning-based (22-24).  
In template-based method, the sCT is derived by spatial transformation from a 
template data. The template image can be generated based on an average image from 
a number of CT image. The spatial transformation information is acquired from co-
registered MR images (25-29). However, the use of template-based method has some 
limitations because the template image cannot fully accommodate the wide inter-
individual anatomical variability of patient image. 
In segmentation-based method, derivation of sCT is performed by MR image 
segmentation and assigning the attenuation coefficients to each segmented tissue 
voxel. For PET/MRI system, one of current clinically available segmentation based 
method is derived from a two-point Dixon sequence to classify soft tissue, fat tissue, 
lungs and background (23). But, there is no contrast difference between air and bone 
due to short relaxation time property of the tissues. Consequently, the bone signal is 
define as soft tissue in attenuation map. Substitution of bone by soft tissue in 
attenuation map cause the underestimation of uptake adjacent to bone regions in not 
only brain but also whole-body imaging. From these problems, ultra-short or zero 
echo time (UTE/ZTE) sequences were proposed to segment the bone tissue (30, 31). 
In their method, the sCT is derived from the difference between two short echo time 
MR images with air mask generated by region growing method. Although the results 
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showed that UTE sequences is feasible to generate attenuation maps, some 
segmentation errors occurred at the borders of the skull and complex small bone and 
air cavities structures. 
In learning-based method, the sCT is generated by automatically machine 
learning the image feature relationship based on different dataset. This method, 
represented as the deep learning, has recently been widely used with high accuracy 
in brain and pelvis regions (32-36). These methods required a large number of 
registered CT and MRI images for training network which means feature 
relationships. While traning is computationally intensitve and time-consuming 
process, but once the initial training is completed, the prediction of sCT can be 
predicted in a short time. Not only is the HU value of sCT image appear very similar 
to the CT, but we can also train by adding a dataset for more acuurate results (37).  
 
1.2. Purpose of Research 
The aim of this thesis is to develop synthetic CT from MRI in diagnostic and 
therapeutic application.  
In chapter 2, we proposed a MR-based attenuation correction (MR-AC) method 
that is based on multi-phase level set algorithm for the brain region. The algorithm 
automatically distinguishes three tissue components, which are air cavities, soft 
tissue and bone region. The accuracy of the proposed MR-AC approach was 
evaluated in clinical studies using simultaneously acquired brain PET/CT and 
PET/MR images.  
In chapter 3, we proposed 2D U-net convolution neural network (CNN) to 
generate sCT from low magnetic field MR images for MR-IGRT. The algorithm was 
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applied to each of the three regions of the pelvis, thorax, and abdomen, and compared 
to sCT and conventional deformed CT (dCT). The feasibility of clinical use of sCT 






Chapter 2. MRI-based Attenuation Correction for 
PET/MRI  
2.1. Background 
As discussed in Chapter 1, the accuracy of attenuation correction of brain PET 
in PET/MRI studies is still questionable. Therefore, commercial simultaneous 
PET/MR scanners use several attenuation correction techniques rather than one 
solution method. 
The first simultaneous PET/MR scanner, Biograph mMR (Siemens Healthcare, 
Erlangen, Germany), offers different MRI-based attenuation correction (MR-AC)  
techniques depending on the imaging site.  
For whole-body scans, 2-point Dixon MR sequence was proposed to classify 
soft tissue, fat tissue, lungs and background (38). In their method, threshold and basic 
image processing were determined to identify and separate the voxel corresponding 
to the each tissue. Although the results showed that there is a similar behavior to CT 
based attenuation correction, it is generally difficult to obtain an optimal threshold 
value due to non-uniform changes and noise. This sequence is also not recommended 
for brain applications, due to an underestimation of PET uptake results (39).  
For brain scan, MR-AC using ultrashort echo time (UTE) MRI sequence 
derives the bone segment based on the difference between two MR images obtained 
at different echo times (ultrashort and typical times) (40, 41). However, the initial 
versions of the UTE sequence (i.e., mMR software version VB18P) yielded frequent 
segmentation errors at the boundary between soft tissue, bone and air, as well as 
misclassification of the ventricle as air (39, 42, 43). Although a recent upgrade of the 
software from VB18P to VB20P offers more reliable attenuation maps than before, 
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significant segmentation errors in the regions around the inferior part of the brain 
(i.e., sinus and lower skull structures) still exist. The images are compared in Figure 
2-2. Moreover, considerable quantification errors because of the inaccurate UTE 
MR-AC have been reported in several articles (39, 42, 43). 
In this study, we propose an advanced UTE MR-AC method that is based on a 
multiphase level-set algorithm (44-46) to provide more accurate attenuation maps 
than those currently used in brain PET/MRI studies. The quantitative accuracy of 
this new method, providing a three–segment (air, bone, and soft tissue) attenuation 









2.2. Materials and Methods 
2.2.1. Brain PET Dataset  
2.2.1.1 Patient Population 
We evaluated our new MR-AC method using two different brain PET data sets. 
One of them was the [18F]fluorinated-N-3-fluoropropyl-2-β-carboxymethoxy-3-β-
(4-iodophenyl)nortropane ([18F]FP-CIT) PET/CT and PET/MRI data acquired for 
evaluating the accuracy of existing MR-AC methods in patients with Parkinson’s 
disease. Total of 20 patients (11 men, 9 women, mean age: 59.6 ± 9.1 y, age range: 
54–71 y) were enrolled in this study. The other was [18F]fluorodeoxyglucose 
([18F]FDG) PET/CT and PET/MRI data of 10 prospectively enrolled healthy normal 
volunteers (6 men, 4 women, mean age: 57.7 ± 5.4 y, age range: 51–67 y) without 
any medical diseases or abnormalities uncovered in neuropsychological screening 
tests.  
2.2.1.2 PET/CT and PET/MRI Acquisition 
PET/CT data were acquired using a Siemens Biograph TruePoint40 scanner 
(Siemens Healthcare, Knoxville, TN) in [18F]FP-CIT studies and a Siemens 
Biograph mCT40 scanner in [18F]FDG studies. A Siemens Biograph mMR system 
was used for PET/MRI data acquisition in both studies. While the mMR software 
version of VB18P was used in the [18F]FP-CIT studies, the software was upgraded 
to VB20P for the [18F]FDG studies. The VB20P is the latest version, and provides 
improved UTE image quality by incorporating gradient delay correction, streak 
artifact suppression and a more advanced MR-AC method. In this new version skull 
segment is generated using template based approach and combined with the soft 
tissue map obtained by applying MRI segmentation. 
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In the [18F]FP-CIT studies, a PET/MRI scan was performed 110 min after the 
injection of a tracer (192 MBq on average) and followed by a PET/CT scan. In the 
[18F]FDG studies, the sequence of PET/MRI and PET/CT were randomly determined, 
and the first scan was performed 40 min after the injection of the tracer (259 MBq 
on average). PET scan duration for [18F]FP-CIT and [18F]FDG was 10 min. 
 
2.2.1.3 PET/CT Data 
PET/CT imaging was performed in a single PET bed position and the 
participants’ heads were positioned in a head holder attached to the patient bed. The 
PET/CT scan followed the routine clinical protocol for brain studies including a 
topogram scan, an attenuation CT scan and a 10 min PET emission scan. For PET 
attenuation correction, the CT images were reconstructed in a 512 × 512 × 112 matrix 
with voxel sizes of 0.59 × 0.59 × 3 mm. The emission PET data were acquired in 
sinogram format. 
 
2.2.1.4 PET/MR Data 
In PET/MRI, the participants’ heads were positioned in the mMR head coil. MR 
images were acquired simultaneously with PET using a dual-echo UTE sequence 
(TE = 0.07 and 2.46 ms, TR = 11.9 ms, flip angle = 10°). The UTE images were 
reconstructed into a 192 × 192 × 192 matrix with an isotropic voxel size of 1.33 mm. 
A T1-weighted 3D ultrafast gradient echo sequence was also acquired in a 208 × 256 




2.2.2. MR-Based Attenuation Map using Level-Set Algorithm  
2.2.2.1. Level-set Segmentation Algorithm 
In the past few decades, deformable active contour models have been widely 
used in image processing, especially for medical image segmentation. It is the curve 
deformed and moved under the influence of external and internal forces.  
The level-set method, also known as the geometric deformable model, 
implicitly represents the contour by the zero level of a high-dimensional function 
called the level-set function ( , , )x y t . If this contour moves in the normal direction 








where the function F is called the speed or energy functional that controls the 
motion of the contour. This approach has advantages over traditional segmentation 
methods such as thresholding and region growing, as it has the ability to represent 
contours with complex topology and to change their topology in a natural way.  
In a variation of the level-set formulation, Chan et al. (44) proposed an active 
contour model using level-set formulation by incorporating region-based 
information. Assuming I is a two-dimensional (2D) image defined on domain Ω, the 
energy functional that we will minimize is defined as, 
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where H is the Heaviside function and c1, c2 are the average image intensities 
in the contour, depending on I and 𝜙. Image segmentation is achieved by solving to 
minimize the energy functional FCV.  
For the segmentation of more than two regions, Vese et al. (45) proposed a 
multiphase level-set approach. Theoretically, N level sets are used to segment up to 
2N regions. In particular, here we used a two-phase level-set method with the 
functions denoted as 𝜙1, 𝜙2 and the energy functional as the following,  
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where C=(c11,c10,c01,c00) is constant vector, and Φ=(𝜙1, 𝜙2) is level set function 
vector. However, the Chan-Vese model is based on the assumption of intensity 
homogeneity. Therefore, local magnetic inhomogeneities and susceptibility effects 
can cause segmentation errors in MR images.  
To address the issue of intensity inhomogeneity in MR image segmentation, Li 
et al. (46) proposed an improved level-set model with a local clustering criterion 
function. This method describes an image with intensity inhomogeneity, defined as 
follows:  
 
,I bJ n   (2.4) 
 
where I is the observed image, J is the true image, b is the bias field, and n is 
additive noise. The method is applied in a circular area with a radius ρ centered at 
each point y in the image domain Ω, defined by Oy≜(x:|x-y|≤ρ) Then, each small 
region is given by: 
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where the constant b(y)ci can be considered to be the approximation of the 
cluster center within the neighborhood Oy. To estimate b(y)ci, the intensities I(x) in 
the neighborhood Oy are classified into N classes. A local intensity criterion function 
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where b(y)ci are the cluster centers to be optimized, K(y-x) is a nonnegative 
weighting function, and a is normalization constant such that ( ) 1K u   . The 
intensity criterion function is integrated over the entire domain Ω and incorporated 
into a multi-phase level-set formulation given by:  
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where M1(𝜙(x))=H(𝜙(x)) and M2(𝜙(x))=1−H(𝜙(x)) in the two-phase case. 
Rp(𝜙) is distance regularization term to make level set function smoothly. By 
minimizing this energy, we obtained the image segmentation result given by the 
level-set function and the estimation of the bias field b. In this work, we employed 
this energy model to segment images using the same parameters as in reference (46), 




2.2.2.2. Characteristic of UTE Images 
The T2 relaxation time of protons in bone tissue is much faster than in other 
tissues. Thus, bone tissues with short T2 can be distinguished from soft tissue by 
taking the subtraction or division between the first ultrashort TE image (UTE1) and 
the second longer TE image (UTE2). However, these images, especially UTE2, are 
sensitive to off-resonance effects because of B0 inhomogeneity and susceptibility, 
causing inhomogeneity artifacts that make accurate image segmentation difficult. 
Thus, we generated UTE MR-based attenuation map based on a level-set algorithm 
in which the intensity inhomogeneity correction was incorporated. These procedures 
were performed using in-house-developed code written in Matlab (R2014a; 
MathWorks, Natick, MA). 
 
2.2.2.3. UTE Image Segmentation using Level-Set Algorithm 
Two-phase level-set segmentation based on the multiphase model was applied 
to both the UTE1 and UTE2, in which two level-set functions were evolved 
simultaneously. Local intensity clustering properties as well as region-based 
information were taken into account to unify the segmentation and inhomogeneity 
correction within a single evolving framework. Figure 2-2 shows the results of the 
level-set segmentation. The final evolved contours (red: level-set function 1 = 0, blue: 
level-set function 2 = 0) are overlaid on the MR images. The regions delimitated by 
the contours were represented in the binary images by assigning one to the inside of 
the contour and zero to the outside (UxLy is the binary image from the yth level-set 
function of the xth UTE in Figure 2-2. The symbol ‘C’ labeled behind y indicates that 




2.2.2.4. Generation of Attenuation Map      
The soft tissue map was obtained by applying a hole-filling operation to the 
U1L1 that encloses almost all of the structures in the head. Air has a negligibly low 
signal in both UTE images. Thus, we obtained an air map by multiplying ~U1L1 and 
~U2L1 in Figure 2-2. To generate the bone map, we started from the initial bone map 
generated by applying a threshold to the difference image (dUTE) between UTE1 
and UTE2 represented in Figure 2-3. The threshold was empirically determined and 
50% of the mean intensity of dUTE pixels >10. This initial bone map was then 
 
Figure 2-2. Generation of soft tissue and air maps and an additional mask using two-phase 
level segmentation and morphological and binary operations. The final evolved contours 
(red: level-set function 1 = 0, blue: level-set function 2 = 0) are overlaid on the MR 
images. UxLy is the binary image from the xth level-set function of the yth UTE. The soft 
tissue and air maps were generated by filling the holes in U1L1 and multiplying two binary 
images (~U1L1 and ~U2L1). Additionally, a mask for trimming the bone map was generated 
from the binary images of the level-set functions obtained using the level-set segmentation 




masked by the morphologically eroded soft tissue map to correct for the 
misclassified voxels around the outer boundary of the skull with air. To further trim 
out the remaining misclassified soft tissue as bone in the dUTE image, we applied 
an additional mask generated by multiplying U2L1C and ~U2L2C (Figure 2-2 and 2-
3). Finally, we added the bone segment to the initial attenuation map, and assigned 
the attenuation coefficients for soft tissue and bone (0.1 cm−1 and 0.151 cm−1).  
 
 
2.2.3. Image Processing and Reconstruction 
Reconstructed PET images were generated from emission data in the PET/CT 
studies using three different attenuation maps. The first one was the MR-based 
attenuation map that is offered by the Biograph mMR software (MR-ACmMR map). 
The second one was the MR-based attenuation map generated using the proposed 
multiphase level-set method (MR-AClevel map). The last one was the CT-based 
 
Figure 2-3. Generation of bone map and final level-set-based attenuation map (MR-
AClevel). Initial bone map generated by applying a threshold to the difference image 
between UTE1 and UTE2 was further trimmed to yield the final bone map by masking it 
with soft tissue map and an additional mask. The MR-AClevel map was then generated by 





attenuation map conventionally used in PET/CT studies, which was converted from 




For each participant, two MR-based attenuation maps were coregistered and 
resliced to the CT-AC map using the Statistical Parametric Mapping (SPM8; 
University of College London, UK) software through the co-registration of T1 3D 
MRI to CT. The PET/CT head holder was visible in the CT-AC map, whereas the 
UTE images were without the head holder. Therefore, the head holder shown in CT 
image was extracted using a region growing segmentation algorithm and added to 
the MR-based attenuation maps to allow a fair comparison. All PET images were 
reconstructed using OP-OSEM (subset = 14, iteration = 3) algorithm through e7tool 
 
Figure 2-4. The overall procedure of image processing and PET reconstruction 
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from Siemens Healthcare. Following reconstruction, all PET data were spatially 
normalized to the SPM standard MRI T1 template to eliminate intersubject anatomic 
variability. The overall image processing steps are summarized in Figure 2-4. 
 
2.3. Results 
The results of CT-AC, MR-ACmMR and MR-AClevel applied to the same emission 
data acquired using PET/CT machines are compared in Figure 2-5 for [18F]FP-CIT 
PET with VB18P mMR software and Figure 2-6 for [18F]FDG PET and VB20P. The 
MR-ACmMR map gave larger air cavities than CT regardless of the version of mMR 
software. The bone tissue in the MR-ACmMR map was underestimated in VB18P 
(Figure 2-5B) and overestimated in VB20P (Figure 2-6B). On the contrary, MR-
AClevel maps (Figures 2-5C and 2-6C) showed more similar properties with CT 
(Figures 2-5A and 2-6A) in the size and shape of the air cavities and bones. While 
the striatal and cerebellar activity in [18F]FP-CIT PET and frontal activity in 
[18F]FDG PET were remarkably underestimated in MR-ACmMR relative to CT-AC 
(Figures 2-5B and 2-6B), MR-AClevel did not show this discrepancy from CT-AC 
(Figures 2-5C and 2-6C). 
The Dice similarity coefficients between MR-AC maps and CT-AC map were 
summarized in Table 2-1. The mean Dice coefficients for bone in MR-AClevel were 
0.60 and 0.79 (VB18P and VB20P) for whole head and 0.71 and 0.83 for cranial 
region only, and all of them were higher than those in MR-ACmMR. There was same 





Figure 2-5. Attenuation maps and [18F]FP-CIT PET images corrected using them. (A) CT, 
(B) MR-ACmMR: MR-based attenuation map generated using mMR software version 
VB18P, (C) MR-level: MR-based attenuation map generated using level-set method. 
 
Figure 2-6. . Attenuation maps and [18F]FDG PET images corrected using them. (A) CT, 
(B) MR-ACmMR using mMR software version VB20P, (C) MR-AClevel. 
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Table 2-1. Dice similarity coefficients for whole head and cranial bone (mean ± standard 
deviation) 
 Whole head Cranial region 
 Dbone Dair Dbone Dair 
[18F] FP-CIT study (n=20)  
MR-ACmMR (VP18P) 0.28 (±0.09) 0.45 (±0.10) 0.31 (±0.11) 0.42 (±0.10) 
MR-AClevel 0.60 (±0.06) 0.54 (±0.09) 0.71 (±0.06) 0.59 (±0.08) 
[18F] FDG study (n=10)  
MR-ACmMR (VP20P) 0.72 (±0.04) 0.60 (±0.06) 0.74 (±0.04) 0.59 (±0.09) 
MR-AClevel 0.79 (±0.02) 0.61 (±0.07) 0.83 (±0.02) 0.62 (±0.10) 
 
The superiority of MR-AClevel to MR-ACmMR was confirmed in the ROI- and 
voxel-based quantitative comparisons. In [18F]FP-CIT studies with MR-ACmMR, the 
percent difference of SUV from CT-AC was greater than –20% in most ROIs (Figure 
2-7A). The percent difference was most remarkable in cerebellum, leading to the 
overestimation of SUVr which was highest in putamen (Figure 2-7A). Conversely, 
the percent difference of [18F]FP-CIT PET with MR-AClevel from CT-AC was 
smaller than 10% in both SUV and SUVr. The binding ratio (BR) values offered by 
the MR-AC methods were linearly correlated with those by CT-AC; nevertheless, 
the MR-AClevel (putamen: y = 1.04x ± 0.016, caudate: y = 1.04x ± 0.021) yielded a 
smaller bias than MR-ACmMR (putamen: y = 1.11x ± 0.038, caudate: y = 1.14x ± 




























Figure 2-10. Correlation of binding ratio (BR) and Bland-Altman analysis in caudate 
nucleus between CT-AC and (A) MR-AClevel, (B) MR-ACmMR in [18F]FP-CIT study 
 
Figure 2-9. Correlation of binding ratio (BR) and Bland-Altman analysis in putamen 





The [18F]FDG PET tests showed a similar trend to the [18F]FP-CIT PET tests, 
while the percent differences in SUV and SUVr between MR-AC and CT-AC were 
roughly half of those in [18F]FP-CIT PET (Figure 2-11, 2-12, and 2-13).  
Figure 2-14 and 2-15 show that there was a remarkable difference in almost 
every brain regions voxel-wise comparison between MR-ACmMR and CT-AC. On the 
contrary the difference between MR-AClevel and CT-AC was limited to the brain 
cortex. In both methods, outer boundary of brain cortex which is vulnerable to the 














Figure 2-12. Correlation of binding ratio (BR) and Bland-Altman analysis in putamen 




Figure 2-13. Correlation of binding ratio (BR) and Bland-Altman analysis in putamen 








Figure 2-15. Paired t-test results of SUV in [18F]FDG PET over whole brain data 
(A) CT-AC > MR-AClevel (B) CT-AC > MR-ACmMR (P<0.05 (FWE), cluster size > 100 
voxels). 
 
Figure 2-14. Paired t-test results of SUV in [18F]FDG PET (A) CT-AC > MR-AClevel  




In this study, we developed a new UTE MR-AC map based on a unified 
multiphase level-set segmentation and inhomogeneity correction method, and 
demonstrated the superior performance of this method over the currently used MR-
AC map in a mMR PET/MRI scanner. The remarkable improvements in the 
segmentation of air cavities and bone and the quantitative accuracy of PET 
measurement using the level-set method were shown in both the [18F]FP-CIT PET 
data using VB18P mMR software and [18F]FDG PET data using VB20P.  
The major upgrade of mMR software from VB18P to VB20P seems to be 
effective in the elimination of misclassification of cerebrospinal fluid in ventricles 
as air and the correction of bone underestimation shown in previous reports. The 
percent error of MR-ACmMR in SUV and SUVr quantification relative to CT-AC was 
reduced approximately by half, although we could not confirm this error reduction 
using the exact same dataset. However, the current VB20P version still yields air 
cavity and bone segmentation errors as shown in Figure 2-6B. However, the MR-
AClevel offered improved segmentation results, leading to the reduction of PET 
quantification error by a factor of approximately three as shown in Figure 2-7.(SUV 
error < 10% in MR-AClevel and < 30% in MR-ACmMR with VB18P, and < 5% in MR-
AClevel and < 15% in MR-ACmMR with VB20P). The evaluation of attenuation maps 
using Dice coefficient confirmed the improvements in the MR-AC maps achieved 
by the level-set method in Table 2-1. For VB20P UTE data sets, MR-AClevel yielded 
the Dice coefficient for bone of 0.83 in cranial region while MR-ACmMR offered 0.74 
in this study and 0.65 in other previous study.  
The results suggest that UTE MR-AClevel provides more accurate PET 
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quantification than Dixon-based AC methods that yielded around 10-20% errors in  
and 5%-15% in depending on brain regions (larger error in cortical regions). Recent 
advanced template-based approach and new approaches with R2* to HU conversion 
and zero-echo-time show similar results to our approach and/or great potential for 
further improvement of MR-AC. The combination of our approach with those 
methods would be the interesting next step that we can take to improve the MR-AC 
in brain and potentially in whole-body PET/MRI studies.  
The advanced results using the level-set method can be attributed to the 
combined effects of various factors in this study. These factors include the 
inhomogeneity correction of UTE images incorporated into the level-set 
segmentation, which led to the more reliable segmentation results. The assorted 
boundary information provided by the multiphase level-set segmentations applied to 
both the UTE images were useful for determining the complex boundaries among 
different segments and trimming the segmentation results through morphological 
operations on the binary images.  
Although MR-AClevel yielded almost equivalent SUV quantification results to 
CT-AC in most brain regions, the errors in cerebellum and occipital cortex were 
larger than in other regions (Figures. 2-7A and 2-11A). The errors in these most 
common reference regions in brain PET studies resulted in positive biases in BR and 
SUVr estimations (Figs. 2-7B and 2-11B, Figure 2-9 and 2-10). It is most likely that 
the errors in these posterior and inferior brain regions are related to the 
misclassification of fat tissues in the neck as bone. This misclassification, also 
observed in Figures 2-5C and 2-6C, is likely caused by the image intensity 
brightening at the periphery of UTE images mainly because of the inhomogeneous 
B1 field associated with multichannel phased array coils.  
 
 ３０
Chapter 3. MR-based synthetic CT generation  
for MR-IGRT 
3.1. Background 
The MRI is increasingly being used in radiotherapy because it provide superior 
soft tissue contrast to delineate tumors and soft tissues. It allows a more precise 
identification of target volume compare to CT and consequently reduce the margin 
expansion from clinical target volume to PTV during the treatment planning. This 
reduction of margin not only reduce the OAR dose, but also shows optimal dose 
coverage for the targe, which is particulary helpful for high dose an 
hypofractionation treastments such as SBRT and SABR (47). 
Despite of several advantages of MRI, one major issue in MR-IGRT is the 
assignment of electron densities to MRI scans for dose calculation. Because the MR 
signals are related to the proton density and relaxation properties of tissue, not to 
electron density. As a result, additional CT imaging is essential to know the radiation 
dose distribution. The common strategy consists in applying rigid or deformable 
registration between MRI and CT simulation images and assigning electron density 
map obtained from the dCT that is shown in Figure 3-1.  
However, there is risk of registration inaccuracy as a result the discrepancies in 
patient position, anatomical changes between scans. In order to overcome these 
difficulties, many attempts have been made to synthesize CT from MR images in 
various ways (24, 27-29, 48). Recently, deep learning-based model have been used 
to generate sCT after training of MR-dCT paired sets (32-36, 49, 50). However, these 





For this purpose, we aimed to develop a synthetic CT generation algorithm wih 
the deep learning method using MR-dCT paired set from MR-IGRT system. We 
investigated the accuracy of the proposed method and performed a dosimetric 







Figure 3-1. Schematic procedure of MR-IGRT treatment  
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3.2. Materials and Methods 
3.2.1. MR-dCT Paired DataSet 
3.2.1.1 Patient Selection 
Total 90 patients data who underwent MR-IGRT were retrospectively 
considered. The study was approved by the institutional review board. The patients 
data can be divided into three categories, 30 with abdomen, 30 with thorax, and 30 
with pelvis. In this study, a synthetic CT model was separately applied to datasets in 
each region. Table 3-1 summarizes patient characteristics.  
 
Table 3-1. Summary of patient characteristics of MR-dCT paired dataset   
Characteristics Parameter Value or Number of patient 
 
For Abdomianl region (n=30)  





Pancreatic cancer 14 
Klatskin tumor 4 













50 Gy / 5 fx 5 
45 Gy / 5 fx 5 
40 Gy / 5 fx 2 
37.5 Gy / 5 fx 1 
60 Gy / 30 fx 2 
56 Gy / 28 fx 4 
54 Gy / 27 fx 2 
50 Gy / 25 fx 5 
30 Gy / 5 fx 1 
27.5 Gy / 5 fx 1 
20 Gy / 5 fx 1 




For Thoracic region (n=30)  





Right breast cancer 18 
Left breast cancer 12 
Treatment 
Technique 
APBI using IMRT 
30 
Prescription dose 38.5 Gy / 10 fx 30 
 
For Pelvic region (n=30)  








IMRT with SIB 13 
SBRT 8 
Prescription dose 
70 Gy / 28 fx 20 
62.5 Gy / 25 fx 2 
36.25 Gy / 5 fx 8 
IMRT = Intensity Modulated Radiation Therapy, SBRT = Stereotactic Body Radiation 
Therapy, APBI = Accelerated partial breast irradiation, SIB = Simultaneous-integrated boost 
 
3.2.1.2 CT and MR Image Acquisition 
For the treatment planning, all patient MRI simulation scan was obtained 15 
min after CT simulation scan, consecutively. The CT images were acquire using a 
Brilliance Big Bore CT scanner (Philips, Cleveland, OH). The MRIdian system 
(ViewRay, Oakwood, OH) was used for 0.35T MRI data acquisition. The MR images 
were acquired using a true fast imaging with steady-state precession (TrueFISP; 
TRUFI) sequence. The MRI scans were obtained with the same patient setup and the 
same immobilization device as the CT simulation. CT images were aligned to the 
corresponding MR images through deformable registration provided ViewRay TPS. 
After registration process, these registered dCT images were resampled to the same 
size of MR images. The accuracy of image registration was visually compared by 
the radiation oncologist and it was excluded from the dataset when the mismatch 
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occurred in the outer and inner contour of patient body. 
 
3.2.1.3 Image Pre-processing 
The workflow of image pre-processing before network training summarized in 
Figure 3-2. First, the dCT images were processed to remove external part of the dCT 
images, such as body frame and coil based on the body region of the MR images. 
Second, blurred image slices at the edges along the axial dimension based on MR 
image were excluded from the dataset. This work was applied to both MR and dCT 
dataset. Third, the center point artifact, which is often caused by MR calibration 
problem, was removed. A series of image pre-processing procedures were performed 
using an in-house Matlab (R2018a; MathWorks, Natick, MA) program. In addition, 
the 0.35T TRUFI sequence MR image intensities may vary between scans and can 
 
Figure 3-2.The workflow of image pre-processing.  
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also be affected by B0 and B1 field nonuniformities. Therefore, N4 bias field 
correction (51), available at open source 3D Slicer 4.6.2, was applied on the MR 
images to remove inhomogeneity.  
The axial diemension of entire MR and dCT dataset was resampled to 320 x 
320 matrix to fit into a CNN architecture. For learning network input, the MR images 
were normalized using a 95% percentile value of each image intensity in each patient, 
and CT images using the maximum value in each patient, respectvely. 
Figure 3-3 shows a pair of MR and dCT images of pelvic, thoracic, abdominal 








3.2.2. Synthetic CT Generation using 2D CNN 
3.2.2.1 Network Architecture 
We utilized 2D CNN to generate a synthetic CT image from paired MR-dCT 
dataset. The 2D CNN network, called U-net by the shape of learning structure, is 
well known successful network for medical image segmentation (52). In the U-net 
architecture, it has a symmetric structure consisting of contracting path and 
expanding path to have the same size as original input image. In addition, there is 
skip connections between contracting and expanding path to provide local 
information to the global information.  
In this study, the 2D CNN U-net architecture introduced by Han (32) was 
adopted and modified. The leaky rectified linear unit (ReLU) was used as activation 
function instead of ReLU. A schematic overall architecture of 2D CNN U-net is 




Figure 3-4. Overall architecture of 2D CNN U-net for generating synthetic CT  
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3.2.2.2 Network Training and Implementation 
The network trained using 2D MR-dCT paired images along axial dimension. 
For each patient region, 24 MR-dCT paired dataset (80% of total paired dataset) were 
randomly selected as the training data and the other 6 paired dataset used as the 
validation data. Data augmentation was performed by flipping all images along the 
horizontal, vertical, and both direction to increas the number of training samples and 
improve generalization of the network. Therefore, we used 4 times the number of 
pre-processed dataset were used in training process. A total of 15246, 16860, and 
9516 image slices were used for pelvic, thoracic, and abdominal region, respectively.  
The learning network was implemented using Tensorflow framework 
(Tensorflow-gpu v1.14.0 and Python v3.6) on single NVIDIA Geforce GTX 1080Ti 
GPU card with 11 GB memory. The network trained 200 epochs with adaptive 
stochastic gradient descent optimizer with a learning rate of 0.0001. Weight and 
biases in the vonvolutional layers and decovolutional layer were trained by 
miniminzing a loss function. The loss function using as the mean absolute error 
(MAE) between the sCT and dCT is defined as,  
 
1








   (3.1) 
  
where i is a voxel within the body and N is the total number of voxels.  
The sCT generation was performed by applying MR images of validation 
dataset to the trained network model. The HU value of sCT was restored considering 
the normailized value applied to each patient. Finally, sCT images were converted 
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DICOM format allowing use in the ViewRay TPS.  
 
3.2.3. Data Analysis  
3.2.3.1 Geometric Analysis 
For each patient, the accuracy of the sCT was evaluated by calculating MAE, 
root mean square error (RMSE), and peak signal-to-noise ratio(PSNR) compared 

































where i is a voxel within the body, N is the total number of voxels, and MAX is 
the maximum pixel value of voxel.  
We also calculated the structural similarity (SSIM), which evaluates the visual 
impact of the three characteristics such as luminance, contrast and structure. The 
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where μx, μx,𝜎x, 𝜎y and 𝜎xy are the local means, standard deviations, and cross-
covariance for images of sCT and dCT. 
 
3.2.3.2 Dosimetric Analysis 
For dosimetric evaluation, the ViewRay TPS for tri-60Co system was employed 
for treatment planning. With the sCT images, dose distribution calculated under the 
identical conditions as the dCT treatment plan. The dose distributions were 
calculated using the MonteCarlo algorithm with calculation grid size of 3mm and 
magnetic field correction included.  
The prescription dose to PTV was not the same for all patient. In order to 
evaluate the dose distribution under the same condition, the scaling process for dose 
was calculated as follows : Pelvis 70 Gy, Thorax 38.5 Gy, Abdomen 50 Gy.   
The comparison between sCT and dCT dose distribution was performed by 
calculating minimum (Dmin), maximum (Dmax) and mean (Dmean) absorbed doses for 
different critical organs and target volumes. In addition, The conformity index (CI) 
and the homogeneity index (HI) for each PTV were calculated as follows:  
 
  100%     Conformity index CI
    
V of the target volume
Volumeof the target volume
  (3.6) 





  (3.7) 
 
To examine the difference between sCT and dCT calculated doses, we 
performed gamma index evaluation (53). Gamma index is a metric used for 
comparing two plans of dose distribution. It allows to express the difference between 
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the plans in a given point in space with a number, which is very important for 
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where rm, rc are the single measurement point and the spatical location of 
calculated distribution relative to the measurement point. The dose-difference 
criterion is Md , and the distance-to-agreement(DTA) criterion is MD . The 
DTA is the distance between a measured data point and the nearest point in the 
calculated dose distribution that exhibits the same dose.  
In this study, gamma criterion of 1 mm/1%, 2 mm/2% and 3 mm/ 3% were used 
and points with doses equal to or less than 10%, 50%, and 90% of the maximum 








3.3.1 Image Comparison  
Pelvic region 
The results of axial, sagittal, and coronal views of input MRI, dCT, and output 
sCT for pelvic region are shown in Figures 3-5, 3-7 and 3-8. The Figure 3-6A shows 
the HU comparison between dCT and sCT. The dCT and sCT profile transecting 
femur bone and prosate are shown at Figure3-6B. The HU values of dCT and sCT 
are represented in the solid and dash lines, respectively.  
According to visual inspection, the sCT produced by 2D CNN matched closely 
to both soft tissue and bone structure compared to dCT. The absolute HU difference 
between CT and sCT is usually small, except for the discrepancy between the edge 
of the bone and the body surface. It can be seen that the air pocket and soft tissue 
close to the superior direction are generated from the structure of the MR image. 
Unlike the axial diemension, discontinuities in soft tisssue and bone were observed 
in coronal and sagittal dimension. 
 
Thoracic region 
The results of axial, sagittal, and coronal views of input MRI, dCT, and output 
sCT for thorax region are shown in Figures 3-9, 3-11 and 3-12. The Figure 3-10A 
shows the HU comparison between dCT and sCT. The dCT and sCT profile 
transecting both lungs, ribs, and mediastinum are shown at Figure 3-10B. The HU 
values of dCT and sCT are represented in the solid and dash lines, respectively.  
The 2D CNN model achieved adequate HU prediction of sCT for soft tissue 
and spine. However, there were difficulties in the generating ribs, which can be also 
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found in the profile in Figure 3-10B. There was a slight overestimation of the sCT 
HU values as can been seen in the overall blueness in the HU differnece map in 
Figure 3-6A. As shown in Figure 3-11, it can be found that the difference HU values 
with discontinuity in the sagittal dimension.  
 
Abdominal region 
The results of axial, sagittal, and coronal views of input MRI, dCT, and output 
sCT for abdomen region are shown in Figures 3-13, 3-15 and 3-16. The Figure 3-
14A shows the HU comparison between dCT and sCT. The dCT and sCT profile 
transecting liver, and stomach are shown at Figure 3-14B. The HU values of dCT 
and sCT are represented in the solid and dash lines, respectively.  
Compared with the results of the previous two regions, the sCT of soft tissue 
and bone structure generated more blurred. Also, the discontinuity is easily obseved 
due to the change in the HU values in coronal dimension as shown in Figure 3-16. 
As shown in Figure 3-14A and 3-14B, it was observed that the sCT HU value of the 






Figure 3-5. The representative axial slice views of MRI, dCT and sCT for pelvis 
 
Figure 3-6. (A) The difference map between 2D CNN model sCT image and the dCT 




Figure 3-7. The representative sagittal slice views of MRI, dCT and sCT for pelvis 
 





Figure 3-9. The representative axial slice views of MRI, dCT and sCT for thorax 
 
Figure 3-10. (A)The difference map between 2D CNN model sCT image and the dCT 





Figure 3-11. The representative sagittal slice views of MRI, dCT and sCT for thorax 
 






Figure 3-13. The representative axial slice views of MRI, dCT and sCT for abdomen 
 
Figure 3-14. (A)The difference map between 2D CNN model sCT image and the dCT 






Figure 3-15. The representative sagittal slice views of MRI, dCT and sCT for abdomen 
 
 




3.3.2 Geomtric Analysis   
For the 6 patients validation dataset in each region, MAE, RMSE, PSNR, and 
SSIM were computed using the equations from 3.2 to 3.5. The Table 3-2 summarized 
the results of geometric parameters. Comparing the average values of MAE, RMSE, 
and PSNR, the values in pelvic region show better acuuracy than the other two region. 
For instance considering the MAE values, the error gradually increases in the order 
of pelvis, thorax, abdomen with 44.02 ± 4.81, 66.36 ± 9.34, and 100.14 ± 36.80, 
respectively. On the other hand, SSIM showed contradictory results.  
 
Table 3-2. Geometric comparison between dCT and sCT with respect to abdomen, thorax, 
and pelvis  
Index Pelvis Thorax Abdomen 
MAE (HU) 44.02 ± 4.81 66.36 ± 9.34 100.14 ± 36.80 
RMSE (HU) 94.26 ± 6.03 108.67 ± 10.30 132.84 ± 32.40 
PSNR (dB) 28.73 ± 0.57 26.73 ± 0.70 25.11 ± 1.85 
SSIM 0.88 ± 0.04 0.87 ± 0.02 0.92 ± 0.01 
 
 
3.3.3 Dosimetric Analysis   
Dose volume histogram (DVH) curves for PTV and relevant OARs in the pelvis, 
thorax, and abdomen are shown in Figure 3-17 A, B, and C, respectively. Figure 3-
17 D, E, and F are enlarged views of each PTV curve. On the graph, the dotted line 
indicated the dCT and the solid line indicated the sCT. It showed that the dose 
distribution of sCT is nearly identical to that of dCT in most structures except the 
PTV in the abdominal region.  
For quantitave analysis, clinically relevant DVH metrics were compared. The 
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mimimum, maximum, and mean value of absolute dose, and percent difference 
values between dCT and sCT in PTV were summarized in Figure 3-18. Comparison 
of all of DVH metrics between dCT and sCT for pelvis, thorax, and abdomen were 
summarized in Table 3-3, 3-4, and 3-5, respectively. The absolute value of PTV does 
not differ significantly between dCT and sCT in all three regions. However, it 
shoewed that dose overestimation of the sCT in PTV about 2% due to the percentage 
difference in Figure 3-18B.    
Differences in OARs dose-volume metrics for each region are presented by box 
plots in Figures 3-19. Tables 3-6, 3-7, and 3-8 showed the average results of 
validation dataset DVH metrics corresponding to the different OARs. Since the p-
values for all metrics are greater than 0.05, there was no significant difference in the 
OARs comparison.  
The dCT-based and sCT-based dose ditribition were compared using gamma 
anaylsis. The Table 3-9 summarized gamma analysis of dose distributions with three 
different dose difference/distance-to agreement criteria : 1 mm/1%, 2 mm/2% and 3 
mm/3%. Considering the 2 mm/2% criterion with a 10% low dose threshold, it 
showed all regions pass rate were above 97 %. If the gamma criterion is changed to 
1 mm/1%, the overall gamma passing rate dcrease, especially in the abdolmen from 
97.12 ± 2.00 to 78.50 ± 7.23. These trend is well llustrated in Figure 3-2 by gamma 











Figure 3-17. DVH curves for the PTV and OARs for (A) pelvis, (B) thorax, (C) abdomen, 
enlarged PTV graph in (D) to (F).  
*DVH : Dose-volume histogram, Dotted line : dCT, Solide line : sCT  
 
Figure 3-18. Box-plot of (A) absolute dose and (B) percent difference in PTV for each 
region. The maximum (top line), 75% (top of box), median (central point), 25% (bottom of 
box), and minimum (bottom line) are shown. Outliers are drawn as points.  
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Table 3-3. Dose-volume metrics of the PTV for pelvis 
DV metric  dCT sCT p-value 
PTV volume (cc) 81.09 ± 19.77 - 
Maximum dose (Gy) 78.70 ± 1.31 79.22 ± 1.29 0.229 
Mean dose (Gy) 73.94 ± 0.72 74.44 ± 0.62 0.042 
Minimum dose (Gy) 63.77 ± 2.13 64.42 ± 1.97 0.040 
D98% (Gy) 68.58 ± 1.04 68.89 ± 0.98 0.222 
D2% (Gy) 76.94 ± 1.11 77.34 ± 0.96 0.081 
V100% (cc) 77.54 ± 18.82 78.52 ± 19.04 0.035 
Homogeneity index 0.11 ± 0.02 0.11 ± 0.02 - 
Conformity index 0.96 ± 0.01 0.97 ± 0.01 - 
 
Table 3-4. Dose-volume metrics of the PTV for thorax 
DV metric dCT sCT p-value 
PTV volume (cc) 95.37 ± 29.80 - 
Maximum dose (Gy) 42.48± 1.36 42.61± 1.64 0.400 
Mean dose (Gy) 40.13 ± 0.64 40.14± 0.77 0.911 
Minimum dose (Gy) 35.28 ± 1.67 35.18 ± 1.65 0.645 
D98% (Gy) 37.67 ± 0.87 37.57± 0.72 0.208 
D2% (Gy) 41.85 ± 1.32 41.92± 1.44 0.517 
V100% (cc) 89.63 ± 27.79 88.11± 27.34 0.070 
Homogeneity index 0.10 ± 0.05 0.11 ± 0.05 - 
Conformity index 0.94 ± 0.01 0.92 ± 0.02 - 
 
 
Table 3-5. Dose-volume metrics of the PTV for abdomen 
DV metric dCT sCT p-value 
PTV volume (cc) 38.27 ± 13.64 - 
Maximum dose (Gy) 54.08 ± 1.20 53.25 ± 1.93 0.242 
Mean dose (Gy) 50.45 ± 2.07 49.63 ± 2.72 0.225 
Minimum dose (Gy) 45.22 ± 2.22 44.41 ± 2.79 0.239 
D98% (Gy) 49.29 ± 0.16 48.57 ± 1.41 0.276 
D2% (Gy) 53.49 ± 0.58 52.90 ± 1.75 0.448 
V100% (cc) 36.10 ± 14.19 34.09 ± 16.61 0.224 
Homogeneity index 0.08 ± 0.01 0.09 ± 0.01 - 







Figure 3-19. Box-plot of absolute dose difference between dCT and sCT in OARs for each 
region. The maximum (top line), 75% (top of box), median (central point), 25% (bottom of 




Table 3-6. Dose-volume metrics of the OARs for pelvis 
DV metric dCT sCT p-value 
Bladder 
Maximum dose (Gy) 75.77 ± 1.55 75.87 ± 1.37 0.551 
Mean dose (Gy) 47.30 ± 3.65 47.51 ± 3.60 0.136 
Minimum dose (Gy) 20.01 ± 10.49 20.13 ± 10.50 0.105 
Rectum 
Maximum dose (Gy) 76.07 ± 1.72 43.24 ± 6.12 0.645 
Mean dose (Gy) 43.22 ± 6.14 43.24 ± 6.12 0.600 
Minimum dose (Gy) 16.61 ± 8.01 16.53 ± 7.95 0.291 
Femur head 
Maximum dose (Gy) 78.70 ± 1.31 79.22 ± 1.29 0.904 
Mean dose (Gy) 73.94 ± 0.72 74.44 ± 0.62 0.068 
Minimum dose (Gy) 63.77 ± 2.13 64.42 ± 1.97 0.167 
 
 
Table 3-7. Dose-volume metrics of the OARs for thorax 
DV metric dCT sCT p-value 
Heart 
Maximum dose (Gy) 19.01± 10.87 19.77 ± 9.95 0.398 
Mean dose (Gy) 3.05 ± 0.73 2.92 ± 0.73 0.327 
Minimum dose (Gy) 0.28 ± 0.09 0.28 ± 0.09 0.856 
Left Lung 
Maximum dose (Gy) 9.05 ± 4.92 9.11 ± 4.84 0.798 
Mean dose (Gy) 1.57 ± 0.31 1.66 ± 0.32 0.472 
Minimum dose (Gy) 0.15 ± 0.03 0.16 ± 0.03 0.447 
Right Lung 
Maximum dose (Gy) 40.09 ± 1.05 39.39 ± 1.05 0.084 
Mean dose (Gy) 6.36 ± 1.36 6.64 ± 1.39 0.389 








Table 3-8. Dose-volume metrics of the OARs for abdomen 
DV metric dCT sCT p-value 
Duodenum 
Maximum dose (Gy) 26.14 ± 8.89 25.89 ± 9.11 0.462 
Mean dose (Gy) 26.14 ± 8.89 25.89 ± 9.11 0.495 
Minimum dose (Gy) 5.35 ± 5.12 5.41± 5.00 0.532 
Liver 
Maximum dose (Gy) 44.46 ± 8.85 43.94 ± 9.52 0.233 
Mean dose (Gy) 8.32 ± 5.26 8.27 ± 5.19 0.291 
Minimum dose (Gy) 0.73 ± 0.33 0.76 ± 0.39 0.170 
Stomach 
Maximum dose (Gy) 45.45 ± 5.19 44.67 ± 5.75 0.459 
Mean dose (Gy) 15.23 ± 5.09 15.09 ± 5.00 0.608 
Minimum dose (Gy) 2.10 ± 1.63 2.16 ± 1.71 0.485 
 
 
Table 3-9. Gamma analysis results comparing the dCT-based plan with sCT-based plan 
Gamma criterion Dose > 10% Dose > 50% Dose > 90% 
Pelvis 
1mm / 1% 87.63 ± 6.86 73.92 ± 17.75 63.25 ± 21.60 
2mm / 2% 98.45 ± 0.95 98.01 ± 2.50 93.26 ± 10.42 
3mm / 3% 99.32 ± 0.68 99.70 ± 0.48 98.96 ± 2.17 
Thorax 
1mm / 1% 91.14 ± 1.25 69.07 ± 3.33 64.28 ± 4.00 
2mm / 2% 99.74 ± 0.07 98.36 ± 0.51 96.06 ± 1.43 
3mm / 3% 99.99 ± 0.01 99.94 ± 0.07 99.85 ± 0.15 
Abdomen 
1mm / 1% 78.50 ± 7.23 28.83 ± 17.61 16.40 ± 17.56 
2mm / 2% 97.12 ± 2.00 81.15± 11.73 40.52 ± 30.93 







 3.4. Discussion 
MR-IGRT with daily adaptive treatment enables to observe tumor reduction in 
real-time. This allows intensive treatment on the remaining tumors while minimizing 
exposure to the surrounding organs. If the tumor size dramatically changes during 
radiotherapy, adaptive MR-IGRT can be used to further reduce normal tissue dose, 
eventually reduce decrease adverse events. Several studies and clinical trials have 
reported promising results in terms of tumour control, toxicity occurrence and 
survival rates using MR-IGRT in breast and pancreatic caner (54-56). In this regard, 
MR-IGRT is the latest treatment technology capable of verification of volumetric 
dose distribution in real time. However, the deformation registration algorithm 
commonly used in MR-IGRT is limited in accuracy, which may lead to inaccurate 
calculation of dose distribution. Therefore, generating synthetic CT from MR images 
acquired in real time is the an alternative way to calculate more accurate dose 
distribution.   
In this study, we applied and assessed 2D CNN U-net model to generate sCT 
for MR-IGRT dose calculation. The 2D CNN U-net model was chosen as a deep 
 





learning method due to much less time-consuming and high accuracy compared to 
the atlas or segmentation based synthetic CT generation method. The difference from 
previously reported studies is that the proposed 2D CNN U-net network is applied 
and compared to three different areas of the pelvis, thorax, and abdomen 
simutaneously.  
To quantiatatively evaluate the quality of the sCT, geometrical analysis and 
dosimetric end analysis were performed. The results demonstrated highly accurate 
and efficient performance in sCT generation. Most of p values in PTV and OARs 
were greater than 0.05, indicating no significant diffrence in dose metrics between 
the dCT and sCT. However, there was a difference in accuracy depending on the 
dataset region. The pelvis and thorax data showed that dCT and sCT were almost 
similar in all the indicators, but the abdomen showed an inferior accuracy compared 
to the two regions. This is due to the degree of mismatch in deformed registration 
bewteen MR and CT. The 2D CNN U-net model valid only when the MR and CT 
images are perfectly registred. It is not feasible given the mismatch between MR and 
CT images by organ motion or air poecket that easily observed in the abdominal 
region. Therefore, using the cycleGAN trained with unpaired samples would have a 
potential improvement on dosimetric accuracy (57-59). 
The dose accuracy of sCT could be predicted through geometric analysis values 
obtained from inter-voxel results of predicted HU values. MAE, RMSE, and PSNR 
all showed high accuracy in the order of pelvis, thorax, and abdomen, which showed 
the same trend in DV metric and gamma analysis. However, since SSIM considered 
all luminance, contrast, and structural characteristics between images, it was difficult 
to find a problem caused by a difference in HU values. Therefore, contrary to the 
previous results, it showed similarity in the order of the abdomen, thorax, and pelvis. 
 
 ５８
From the image comparison results, HU estimation of bony stsuctures were not 
sufficiently represented on the sCT. One possible reason could be the large 
interpatient variability of CT intensity distribution within bony structure (34). To 
solve this problem, adding additional anatomical information in the training data for 
the 2D CNN U-net could further improve the CT number estimation accuracy. In the 
process of radiotherpay, it was requried contouring of tumor and normal organs. 
Therefore, in preparing the data set, additional contouring of the air pocket and the 
bone can improve accuracy.  
 
 ５９
Chapter 4. Conclusions 
We have developed an UTE MR-AC method using level-set segmentation with 
inhomogeneity correction for brain PET/MRI studies, and demonstrated the 
feasibility of this method in brain PET/MRI studies with [18F]FP-CIT and [18F]FDG. 
The MR-based attenuation maps generated using level-set segmentation and PET 
images corrected for attenuation and scatter using it was superior to those offered by 
the manufacturer of the PET/MRI system in terms of the similarity to the CT-AC. 
This method will be useful for improving the quantitative accuracy of brain PET in 
PET/MRI studies. 
We have applied 2D CNN U-net network and evaluated the low field MR-based 
sCT compared to dCT. It can generate accurate sCT images from low field MR 
images fully automatic within seconds. Compared with dCT generated by deformed 
registration, the sCT provided low dose uncerttainties by DVH metric and gamma 
analysis. Therefore, the proposed method clinically acceptable for MR-IGRT 








1. Schlemmer HP, Pichler BJ, Schmand M, Burbar Z, Michel C, Ladebeck R, et al. 
Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology. 
2008;248(3):1028-35. 
2. Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Cherry SR. Simultaneous 
acquisition of multislice PET and MR images: initial results with a MR-compatible PET 
scanner. J Nucl Med. 2006;47(12):1968-76. 
3. Pichler BJ, Judenhofer MS, Catana C, Walton JH, Kneilling M, Nutt RE, et al. 
Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. 
J Nucl Med. 2006;47(4):639-47. 
4. Yoon HS, Ko GB, Kwon SI, Lee CM, Ito M, Chan Song I, et al. Initial results of 
simultaneous PET/MRI experiments with an MRI-compatible silicon photomultiplier PET 
scanner. J Nucl Med. 2012;53(4):608-14. 
5. Yamamoto S, Watabe T, Watabe H, Aoki M, Sugiyama E, Imaizumi M, et al. 
Simultaneous imaging using Si-PM-based PET and MRI for development of an integrated 
PET/MRI system. Phys Med Biol. 2012;57(2):N1-13. 
6. Catana C, Drzezga A, Heiss WD, Rosen BR. PET/MRI for neurologic applications. 
J Nucl Med. 2012;53(12):1916-25. 
7. Jaffray DA. Image-guided radiotherapy: from current concept to future 
perspectives. Nat Rev Clin Oncol. 2012;9(12):688-99. 
8. Goyal S, Kataria T. Image guidance in radiation therapy: techniques and 
applications. Radiol Res Pract. 2014;2014:705604. 
9. Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, et al. 
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College 
of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). 
Int J Radiat Oncol Biol Phys. 2009;73(1):9-14. 
10. Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, et al. 
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage 
I non-small cell lung cancer. Strahlenther Onkol. 2014;190(1):26-33. 
11. Boda-Heggemann J, Lohr F, Wenz F, Flentje M, Guckenberger M. kV cone-beam 
CT-based IGRT: a clinical review. Strahlenther Onkol. 2011;187(5):284-91. 
12. Martins L, Couto JG, Barbosa B. Use of planar kV vs. CBCT in evaluation of setup 
errors in oesophagus carcinoma radiotherapy. Rep Pract Oncol Radiother. 2016;21(1):57-62. 
13. Mutic S, Dempsey JF. The ViewRay system: magnetic resonance-guided and 
controlled radiotherapy. Semin Radiat Oncol. 2014;24(3):196-9. 
14. Henke LE, Contreras JA, Green OL, Cai B, Kim H, Roach MC, et al. Magnetic 
Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience. Clin 
Oncol (R Coll Radiol). 2018;30(11):720-7. 
15. Hu Y, Rankine L, Green OL, Kashani R, Li HH, Li H, et al. Characterization of the 
onboard imaging unit for the first clinical magnetic resonance image guided radiation therapy 
system. Med Phys. 2015;42(10):5828-37. 
16. Kim JI, Lee H, Wu HG, Chie EK, Kang HC, Park JM. Development of patient-
controlled respiratory gating system based on visual guidance for magnetic-resonance image-
guided radiation therapy. Med Phys. 2017;44(9):4838-46. 
17. Green OL, Rankine LJ, Cai B, Curcuru A, Kashani R, Rodriguez V, et al. First 
clinical implementation of real-time, real anatomy tracking and radiation beam control. Med 
Phys. 2018. 
18. Carney JP, Townsend DW, Rappoport V, Bendriem B. Method for transforming CT 
images for attenuation correction in PET/CT imaging. Med Phys. 2006;33(4):976-83. 
19. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for 




20. Saw CB, Loper A, Komanduri K, Combine T, Huq S, Scicutella C. Determination 
of CT-to-density conversion relationship for image-based treatment planning systems. Med 
Dosim. 2005;30(3):145-8. 
21. Ahnesjo A, Andreo P, Brahme A. Calculation and application of point spread 
functions for treatment planning with high energy photon beams. Acta Oncol. 1987;26(1):49-
56. 
22. Keereman V, Mollet P, Berker Y, Schulz V, Vandenberghe S. Challenges and 
current methods for attenuation correction in PET/MR. MAGMA. 2013;26(1):81-98. 
23. Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation 
correction in PET: methods and challenges. MAGMA. 2013;26(1):99-113. 
24. Edmund JM, Nyholm T. A review of substitute CT generation for MRI-only 
radiation therapy. Radiat Oncol. 2017;12(1):28. 
25. Kops ER, Herzog H, Shah NJ. Comparison template-based with CT-based 
attenuation correction for hybrid MR/PET scanners. EJNMMI Phys. 2014;1(Suppl 1):A47. 
26. Montandon ML, Zaidi H. Atlas-guided non-uniform attenuation correction in 
cerebral 3D PET imaging. Neuroimage. 2005;25(1):278-86. 
27. Andreasen D, Van Leemput K, Edmund JM. A patch-based pseudo-CT approach 
for MRI-only radiotherapy in the pelvis. Med Phys. 2016;43(8):4742. 
28. Sjolund J, Forsberg D, Andersson M, Knutsson H. Generating patient specific 
pseudo-CT of the head from MR using atlas-based regression. Phys Med Biol. 
2015;60(2):825-39. 
29. Uh J, Merchant TE, Li Y, Li X, Hua C. MRI-based treatment planning with pseudo 
CT generated through atlas registration. Med Phys. 2014;41(5):051711. 
30. Leynes AP, Yang J, Shanbhag DD, Kaushik SS, Seo Y, Hope TA, et al. Hybrid 
ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic 
lesions in PET/MRI. Med Phys. 2017;44(3):902-13. 
31. Delso G, Wiesinger F, Sacolick LI, Kaushik SS, Shanbhag DD, Hullner M, et al. 
Clinical evaluation of zero-echo-time MR imaging for the segmentation of the skull. J Nucl 
Med. 2015;56(3):417-22. 
32. Han X. MR-based synthetic CT generation using a deep convolutional neural 
network method. Med Phys. 2017;44(4):1408-19. 
33. Nie D, Trullo R, Lian J, Petitjean C, Ruan S, Wang Q, et al. Medical Image 
Synthesis with Context-Aware Generative Adversarial Networks. Med Image Comput 
Comput Assist Interv. 2017;10435:417-25. 
34. Chen S, Qin A, Zhou D, Yan D. Technical Note: U-net-generated synthetic CT 
images for magnetic resonance imaging-only prostate intensity-modulated radiation therapy 
treatment planning. Med Phys. 2018;45(12):5659-65. 
35. Dinkla AM, Wolterink JM, Maspero M, Savenije MHF, Verhoeff JJC, Seravalli E, 
et al. MR-Only Brain Radiation Therapy: Dosimetric Evaluation of Synthetic CTs Generated 
by a Dilated Convolutional Neural Network. Int J Radiat Oncol Biol Phys. 2018;102(4):801-
12. 
36. Maspero M, Savenije MHF, Dinkla AM, Seevinck PR, Intven MPW, Jurgenliemk-
Schulz IM, et al. Dose evaluation of fast synthetic-CT generation using a generative 
adversarial network for general pelvis MR-only radiotherapy. Phys Med Biol. 
2018;63(18):185001. 
37. Lundervold AS, Lundervold A. An overview of deep learning in medical imaging 
focusing on MRI. Z Med Phys. 2019;29(2):102-27. 
38. Christen T, Sheikine Y, Rocha VZ, Hurwitz S, Goldfine AB, Di Carli M, et al. 
Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET 
imaging. JACC Cardiovasc Imaging. 2010;3(8):843-51. 
39. Dickson JC, O'Meara C, Barnes A. A comparison of CT- and MR-based attenuation 
correction in neurological PET. Eur J Nucl Med Mol Imaging. 2014;41(6):1176-89. 
40. Keereman V, Fierens Y, Broux T, De Deene Y, Lonneux M, Vandenberghe S. MRI-




41. Catana C, van der Kouwe A, Benner T, Michel CJ, Hamm M, Fenchel M, et al. 
Toward implementing an MRI-based PET attenuation-correction method for neurologic 
studies on the MR-PET brain prototype. J Nucl Med. 2010;51(9):1431-8. 
42. Cabello J, Lukas M, Forster S, Pyka T, Nekolla SG, Ziegler SI. MR-based 
attenuation correction using ultrashort-echo-time pulse sequences in dementia patients. J 
Nucl Med. 2015;56(3):423-9. 
43. Choi H, Cheon GJ, Kim HJ, Choi SH, Lee JS, Kim YI, et al. Segmentation-based 
MR attenuation correction including bones also affects quantitation in brain studies: an initial 
result of 18F-FP-CIT PET/MR for patients with parkinsonism. J Nucl Med. 
2014;55(10):1617-22. 
44. Chan TF, Vese LA. Active contours without edges. Ieee T Image Process. 
2001;10(2):266-77. 
45. Vese LA, Chan TF. A multiphase level set framework for image segmentation using 
the Mumford and Shah model. Int J Comput Vision. 2002;50(3):271-93. 
46. Li C, Huang R, Ding Z, Gatenby JC, Metaxas DN, Gore JC. A level set method for 
image segmentation in the presence of intensity inhomogeneities with application to MRI. 
IEEE Trans Image Process. 2011;20(7):2007-16. 
47. Park JM, Park SY, Kim HJ, Wu HG, Carlson J, Kim JI. A comparative planning 
study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy 
system and volumetric modulated arc therapy. Radiother Oncol. 2016;120(2):279-85. 
48. Largent A, Barateau A, Nunes JC, Lafond C, Greer PB, Dowling JA, et al. Pseudo-
CT Generation for MRI-Only Radiation Therapy Treatment Planning: Comparison Among 
Patch-Based, Atlas-Based, and Bulk Density Methods. Int J Radiat Oncol Biol Phys. 
2019;103(2):479-90. 
49. Fu J, Yang Y, Singhrao K, Ruan D, Chu FI, Low DA, et al. Deep learning 
approaches using 2D and 3D convolutional neural networks for generating male pelvic 
synthetic computed tomography from magnetic resonance imaging. Med Phys. 
2019;46(9):3788-98. 
50. Largent A, Barateau A, Nunes JC, Mylona E, Castelli J, Lafond C, et al. 
Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation 
in MRI-Based Prostate Dose Planning. Int J Radiat Oncol Biol Phys. 2019;105(5):1137-50. 
51. Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: 
improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310-20. 
52. Olaf Ronneberger PF, Thomas Brox. U-Net: Convolutional Networks for 
Biomedical Image Segmentation. arXiv. 
53. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative 
evaluation of dose distributions. Med Phys. 1998;25(5):656-61. 
54. Jeon SH, Shin KH, Park SY, Kim JI, Park JM, Kim JH, et al. Seroma change during 
magnetic resonance imaging-guided partial breast irradiation and its clinical implications. 
Radiat Oncol. 2017;12(1):103. 
55. Mittauer K, Paliwal B, Hill P, Bayouth JE, Geurts MW, Baschnagel AM, et al. A 
New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for 
Abdominal and Thoracic Malignancies. Cureus. 2018;10(4):e2422. 
56. Boldrini L, Cusumano D, Cellini F, Azario L, Mattiucci GC, Valentini V. Online 
adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls 
and pitfalls. Radiat Oncol. 2019;14(1):71. 
57. Zhu J Y PT, Isola P, Efros A A. Unpaired Image-to-Image Translation using Cycle-
Consistent Adversarial Networks. IEEE  International Conference on Computer Vision. 
2017. 
58. Klages P, Benslimane I, Riyahi S, Jiang J, Hunt M, Deasy JO, et al. Patch-based 
generative adversarial neural network models for head and neck MR-only planning. Med 
Phys. 2020;47(2):626-42. 
59. Dong X, Lei Y, Tian S, Wang T, Patel P, Curran WJ, et al. Synthetic MRI-aided 
 
 ６３
multi-organ segmentation on male pelvic CT using cycle consistent deep attention network. 







Abstract in Korean (국문 초록) 
 
지난 10년간 진단 및 치료분야에서 자기공명영상(Magnetic resonance 
imaging; MRI) 의 적용이 증가하였다. MRI는 CT와 비교해 추가적인 
전리방사선의 피폭없이 뇌, 복부 기관 및 골수 등에서 더 높은 연조직 
대비를 제공한다. 따라서 MRI를 적용한  양전자방출단층촬영(Positron 
emission tomography; PET)/MR 시스템과 MR 영상 유도 방사선 치료 
시스템(MR-image guided radiation therapy; MR-IGRT)이 진단 및 치료 
방사선분야에 등장하여 임상에 사용되고 있다.  
PET/MR 시스템의 한 가지 주요 문제는 PET 정량화를 위한 MRI 
스캔으로부터의 감쇠 보정이며, MR-IGRT 시스템에서 선량 계산을 위해 
MR 영상에 전자 밀도를 할당하는 것과 비슷한 필요성을 찾을 수 있다. 
이는 MR 신호가 전자 밀도가 아닌 조직의 양성자 밀도 및 T1, T2 이완 
특성과 관련이 있기 때문이다. 이 문제를 극복하기 위해, MR 
이미지로부터 유래된 가상의 CT인 합성 CT라 불리는 방법이 
제안되었다. 본 학위논문에서는 합성 CT 생성 방법 및 진단 및 방사선 
치료에 적용을 위한 MR 영상 기반 합성 CT 사용의 임상적 타당성을 
조사하였다.  
첫째로, 뇌 PET/MR를 위한 레벨셋 분할을 이용한 MR 이미지 기반 
감쇠 보정 방법을 개발하였다. MR 이미지 기반 감쇠 보정의 부정확성은 
정량화 오류와 뇌 PET/MRI 연구에서 병변의 잘못된 판독으로 이어진다. 
이 문제를 해결하기 위해, 자기장 불균일 보정을 포함한 다상 레벨셋 
 
 ６５
알고리즘에 기초한 개선된 초단파 에코 시간 MR-AC 방법을 제안하였다. 
또한 CT-AC 및 PET/MRI 스캐너 제조업체가 제공한 MR-AC와 비교하여 
레벨셋 기반 MR-AC 방법의 임상적 사용가능성을 평가하였다. 
둘째로, MR-IGRT 시스템을 위한 심층 컨볼루션 신경망 모델을 
사용하여 저필드 MR 이미지에서 생성된 합성 CT 방법를 제안하였다. 
이 합성 CT 이미지를 변형 정합을 사용하여 생성된 변형 CT와 비교 
하였다. 또한 골반, 흉부 및 복부 환자에서의 기하학적, 선량적 분석을 
통해 방사선 치료계획에서의 합성 CT를 사용가능성을 평가하였다. 
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